Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New Amgen compounds for disorders mediated by TNF-alpha, collagenase and/or stromelysin

July 20, 1999

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

July 19, 1999

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

AdProTech presents data on its membrane-active complement inhibitor

July 16, 1999

CSAID from Italfarmaco prevents de novo formation of B1 receptors

July 15, 1999

New series from Novo Nordisk useful for pain, inflammation, NIDDM, etc.

July 15, 1999

TT-232, a new somatostatin analogue, effective against neurogenic and non-neurogenic inflammation

July 14, 1999

Novel pyridazines from Kowa inhibit cytokine production

July 14, 1999

New MMP inhibitors, their preparation and use described by Pfizer scientists

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...